Product image of Moxifloxacina Krka (Moxifloxacin) supplied by GNH India

Moxifloxacina Krka

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxifloxacina Krka (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxifloxacina Krka, is a fluoroquinolone presented as an oral tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, sinusitis, bronchitis, skin infections and intra‑abdominal infections in adult patients.

GNH India supplies Moxifloxacina Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxifloxacina Krka is a fluoroquinolone antibacterial indicated for several bacterial infections.

  • Community‑acquired bacterial pneumonia: achieves clinical cure and bacterial eradication.
  • Acute bacterial sinusitis: reduces symptoms and eliminates the causative pathogens.
  • Acute bacterial exacerbation of chronic bronchitis: improves airflow and resolves infection.
  • Skin and skin structure infections: clears bacterial involvement and promotes healing.
  • Intra‑abdominal infections: provides effective bacterial clearance in complicated cases.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the unwinding and resealing of DNA strands, leading to inhibition of bacterial cell division and ultimately bacterial cell death. This bactericidal activity is broad‑spectrum against Gram‑positive, Gram‑negative and atypical organisms.

Side Effects

Moxifloxacina Krka may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness
  • Abdominal pain
  • Rash

Serious or Rare Side Effects

  • Tendon rupture or tendinitis
  • QT interval prolongation leading to arrhythmia
  • Clostridioides difficile‑associated colitis
  • Severe allergic reactions (anaphylaxis, Stevens‑Johnson syndrome)
  • Hepatic dysfunction
  • Photosensitivity

Precautions & Warnings

Before prescribing Moxifloxacina Krka, clinicians should consider several safety measures.

  • Assess renal function: adjust use in severe impairment.
  • Review cardiac history: avoid in patients with known QT prolongation.
  • Avoid concomitant use with other fluoroquinolones.
  • Monitor for tendon pain: discontinue if symptoms arise.
  • Use with caution in pregnancy: limited safety data available.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Moxifloxacina Krka can interact with other medicines, requiring careful management.

Major Interactions (Avoid)

  • Concomitant use with systemic corticosteroids: increased risk of tendon rupture.
  • Co‑administration with QT‑prolonging drugs (e.g., quinidine, macrolides): heightened arrhythmia risk.
  • Combination with antacids containing aluminum or magnesium: markedly reduces moxifloxacin absorption.

Moderate Interactions (Monitor Closely)

  • Warfarin: may enhance anticoagulant effect; monitor INR.
  • Theophylline: increased plasma levels; watch for toxicity.
  • Cyclosporine: elevated exposure; monitor renal function.

Frequently Asked Questions

Moxifloxacina Krka is prescribed for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, skin and skin‑structure infections, and intra‑abdominal infections that require a broad‑spectrum fluoroquinolone.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. This inhibition stops bacterial cells from multiplying, leading to bacterial death and resolution of the infection.

The dosage of Moxifloxacina Krka is determined by the prescribing clinician based on the specific infection, patient characteristics and local guidelines. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for moxifloxacin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxifloxacin offers a broader spectrum against atypical pathogens and a longer half‑life, allowing once‑daily dosing in many cases. Compared with older fluoroquinolones, it may have a lower risk of certain resistance patterns but shares class‑related safety considerations such as tendon toxicity and QT prolongation.

Moxifloxacina Krka should be stored below 25 °C in its original packaging, protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency.

The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Patients should swallow the tablet whole with a full glass of water and avoid crushing or chewing unless specifically instructed.

Serious risks include tendon rupture or tendinitis, QT interval prolongation that can lead to arrhythmias, severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome, and Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience any of these symptoms.

Moxifloxacina Krka is contraindicated in patients with a known hypersensitivity to moxifloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals with significant QT prolongation or uncontrolled cardiac arrhythmias.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT